▲ BUY
9
/ 10
Conviction
$ Value
$10K
Shares
6,060
Price
$2
Filed
Sep 11
▶ Why this score? (9/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Cluster: 7 insiders buying (+2)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Mandel-Brehm Josh
Title
Chief Executive Officer
CIK
0001927058
Roles
Director
Officer
Transaction Details
Transaction Date
2025-09-11
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
278,417
Footnotes
On September 11, 2025, the reporting person acquired shares in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.
Filing Info
Mandel-Brehm Josh's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | CAMP | A | $0 |
| 2025-12-11 | CAMP | A | $0 |
| 2025-09-11 | CAMP | ▲ | $10K ★ |
| 2025-06-12 | PMN | A | $0 |
Other Insiders at CAMP (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| MacLean Michael F | — | — | 2026-04-01 |
|
Maricich Yuri
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Mandel-Brehm Josh
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Gold Kelly
Chief Financial Officer
|
— | — | 2026-04-01 |
|
Tardiff Daniel
Chief Scientific Officer
|
— | — | 2026-04-01 |